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A collection of 39 methicillin-resistant Staphylococcus aureus (MRSA) strains derived from six different
hospitals in Ankara and one hospital in Barsa, Turkey, were analyzed by multiple genotyping. In agreement
with the other genotyping assays, pulsed-field gel electrophoresis of DNA macrorestriction fragments identified
genetic homogeneity among all MRSA isolates studied. It is concluded that a major clone of MRSA has spread
through a large part of Turkey, causing longitudinally persistent colonization in all of the institutions surveyed.
Staphylococcus aureus has remained a major cause of noso-
comial morbidity and mortality, and as an additional clinical
problem, methicillin-resistant S. aureus (MRSA) emerged at
an alarming rate in the 1980s (8, 9). Consequently, analysis of
the dissemination of MRSA isolates has been a research focus
for the past decade. Resistance to methicillin, which is often
accompanied by other forms of antimicrobial resistance, is
usually a direct consequence of the acquisition of another
penicillin-binding protein (PBP 2a) gene, called mecA (7). In
addition to mecA regulatory genes like mecI and mecR, nu-
merous auxiliary genes contributing to the overall level of
methicillin resistance of a strain have been identified (5). Ap-
parently, the genetic background in which the mecA gene is
embedded is of immediate importance to the clinical threat
that a given strain poses. Analysis of the genetic background by
molecular typing techniques is important in the sense that
specific DNA characteristics may be correlated with important
phenomena such as strain epidemicity and virulence. Interna-
tional epidemiologic surveillance requires reliable techniques
capable of differentiating independent strains from clonally
related strains, and molecular pheno- and genotyping tech-
niques have been optimized for the purpose of studying the
spread of MRSA. All procedures applied thus far have specific
experimental drawbacks (17). Pulsed-field gel electrophoresis
(PFGE) has proven to be highly discriminatory for MRSA
isolates, and it has been suggested that it is superior to other
genotyping techniques. However, this method is fairly labori-
ous, and the DNA restriction patterns may be difficult to in-
terpret (18). Moreover, interlaboratory standardization of
PFGE is still problematic (2). Randomly amplified polymor-
phic DNA analysis has proven to be a rapid technique that
yields epidemiologically valid results. Again, however, its in-
terlaboratory reproducibility needs improvement (20). Thus,
the continued need for accurate genotyping systems that can
be applied in clinical laboratories is evident. It has been sug-
gested that only the combined application of various typing
schemes allows for an accurate analysis of clonal relatedness
among MRSA isolates (12).
In the present study a collection of MRSA strains from six
different hospitals in the Ankara region and a single hospital in
the city of Bursa, 380 km apart in Turkey, were analyzed by
multiple genotyping procedures. The use of ribotyping, ran-
dom amplification of polymorphic DNA, isolate-specific DNA
probes, and PFGE enables assessment of the putative clonal
spread of MRSA in that part of the world.
Bacterial strains, cultivation, and antibiotic susceptibility
testing. A collection of 39 MRSA strains was obtained from
seven different hospitals, of which six are located in Ankara
(hospital A, Department of Infectious Diseases and Clinical
Microbiology, Medical School, Uledag University, Bursa; hos-
pital B, Department of Bacteriology, Medical School, Ankara
University, Ankara; hospital C, Department of Bacteriology,
Medical School, Ankara; Hacittepe hospital D, Department of
Bacteriology, Medical School, Gazi University, Ankara; E,
Yuksek Intisas Hospital, Turkish Ministry of Health, Ankara;
hospital F, Department of Infectious Diseases and Clinical
Microbiology, Gulhane Military Medical Academy, Ankara;
and hospital G, Medical School, Cebeci Hospital, Ankara Uni-
versity, Ankara). Colonies were selected on the basis of mor-
phological characteristics, checked by Gram staining, and
tested for catalase and coagulase production. Coagulase pro-
duction was assayed by the citrate-plasma tube technique (11).
Swabs were inoculated directly onto 5% blood agar, mannitol
salt agar, and DNase test medium. Subsequently, the swabs
were incubated in broth enrichment medium with 6.5% NaCl
(378C for 18 h) or Stuart’s transport medium (7 days at 48C)
(11). All solid media were incubated at 378C for 16 h, after
which the plates were placed at room temperature. Semiquan-
titative detection of susceptibility toward antibiotics, specif-
ically, oxacillin and methicillin, was performed by well-es-
tablished disc diffusion procedures (10). All antibiotics
except cefoperazone-sulbactam were purchased from Oxoid
(Unipath, Haarlem, The Netherlands); cefaperazone-sulbac-
tam was purchased from BBL (Becton Dickinson, Etten-Leur,
The Netherlands).
DNA isolation. For DNA isolation, bacteria were grown in
suspension in brain heart infusion broth for 18 h at 378C.
Spheroplasts were produced by incubation with lysostaphin
and were lysed by the addition of 1 ml of 4 M guanidinium
isothiocyanate–50 mM Tris z HCl (pH 6.4)–3 mM EDTA–1%
(wt/wt) Triton X-100. DNA was purified by Celite affinity chro-
matography (1a). Stock solutions of bacterial DNA were ad-
justed to a concentration of 5 ng per 10 ml and were stored at
2208C.
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Ribotyping. Conventional ribotyping with EcoRI was per-
formed by methods described previously (6). Restriction frag-
ments were Southern blotted onto Hybond N1 membranes
(Amersham, Buckinghamshire, United Kingdom) (13), and
the Escherichia coli 16S rRNA gene, amplified by PCR, was
used as a probe. Hybridization was detected by using the en-
hanced chemiluminescent Amersham ECL kit (Amersham).
Arbitrarily primed PCR. PCR was performed essentially as
described before (20). Cycling was performed in Biomed PCR
machines (model 60) and consisted of the following steps:
predenaturation at 948C for 4 min and 35 cycles of 1 min at
948C, 1 min at 258C, and 2 min at 748C. The primer used to
discriminate S. aureus strains was ERIC2 (59-AAGTAAGTG
ACTGGGGTGAGCG-39), which was previously shown to ef-
fectively discriminate among both methicillin-susceptible S.
aureus and MRSA strains (23). Amplification products were
separated by electrophoresis in 1% agarose gels (Hispanagar;
Sphaero Q, Leiden, The Netherlands). Gels were photo-
graphed with a Polaroid MP4 Landcamera and Polaroid 57
High-Speed films. The banding patterns visualized in this man-
ner were indexed with capital letters. Even single band differ-
ences led to the definition of a novel type.
PFGE. PFGE was performed with a CHEF Mapper (Bio-
Rad, Veenendaal, The Netherlands) in the autoalgorithm
mode (2). DNA was digested with the restriction enzyme SmaI
(New England Biolabs, Hitchin, United Kingdom). Several
strains from geographically diverse regions were included as
control strains for the determination of resemblance to the
Turkish strains. Interpretation was done by using previously
determined standards (18). All bands were scored manually for
their presence or absence in a given PFGE fingerprint. Band-
ing patterns were translated into a binary code, and phyloge-
netic trees were constructed with the help of computer pro-
grams accessible through the Internet (PHYLIP, version 3.5c;
Phylogeny Interference Package, University of Seattle, Seattle,
Wash.). The maximum likelihood method was used to estimate
phylogenetic distances between strains.
Hybridization studies with isolate-specific DNA probes.Dif-
ferentiation of staphylococcal strains can be based upon their
reactivities toward isolate-specific DNA probes (21). Southern
blots of purified staphylococcal DNA were prepared as de-
scribed above (see ribotyping section). Probe labelling, hybrid-
ization, and detection were performed with the ECL direct
labelling and detection systems (Amersham). Six different
DNA probes were applied, and hybridization was scored as
plus or minus according to the presence or absence of hybrid-
ization signal, respectively.
Results of the typing studies. Upon antibiotic susceptibility
testing it became apparent that all strains except strain C4
produced b-lactamase and were uniformly resistant to oxacil-
lin, methicillin, tobramycin, penicillin, cefuroxime, cefataxim,
ceftazidime, piperacillin, flucloxacillin, cefipime, metronida-
zole, aztreonam, and cefaperazone-sulbactam. Toward the
other antibiotics tested (ciprofloxacin, ofloxacin, netilmicin,
erythromycin, tetracycline, imipenem, chloramphenicol, and
co-trimoxazole), differential susceptibility was found, although
toward erythromycin and tetracycline only resistant and inter-
mediately resistant phenotypes were found. There appeared to
be no close relationship between the antibiogram and the orig-
inating hospital.
Only two different but closely related ribotypes could be
detected. Either five (type A) or six (type B) DNA fragments
hybridized to the rRNA gene probe. The B type was docu-
mented in 8 of 39 strains (prevalence, 21%) and occurred in
five of seven institutions. In hospital C the incidence of type B
was 60%, possibly indicating spread among the patients nursed
there and that the type is endemic. In hospitals G and D the B
type was not encountered. Arbitrarily primed PCR with primer
ERIC2 revealed three different patterns only. The two most
frequently observed types (types A and B) differed by a single
band, whereas the most aberrant type (type C) occurred only
once (strain C5, hospital C). Although there appeared to be no
100% overlap, the arbitrarily primed PCR B type seemed to be
linked to a B ribotype. Probing of genomic DNA with DNA
probes capable of differentiating among the MRSA strains (21)
fully corroborated the arbitrarily primed PCR and ribotyping
data.
PFGE was carried out to obtain definite proof of the ob-
served homogeneity of this cluster of MRSA isolates. The gels
are shown in Fig. 1. Overall, 31 different, position-based bands
could be observed, and the pattern obtained for each strain was
scored for the absence or presence of each band. On the basis
FIG. 1. PFGE of SmaI macrorestriction fragments of MRSA isolates from the Ankara region and Bursa. The numbering above the lanes and the letters beneath
the panels identify the strains. The numbers between the panel labeled Random and panel A indicate the DNA fragment numbering used for position scoring.
(Random) Analysis of some reference strains: lanes 1 and 2, isolates from the Iberian clone (14); lanes 3 and 4, isolates of the major Polish clone AA; lanes 5 to 8,
isolates of the major Polish clone BB (19). Note that some banding features of the Polish BB type are shared with the Turkish strains; identity is not obvious, however.
On the right three molecular length markers are given (10, 5, and 1 Mb, from top to bottom, respectively).
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of this band presence score a phylogenetic tree could be con-
structed (Fig. 2). Except for strain C5, all of the MRSA isolates
fell within a 10% difference margin compared to the average
homology value of 90%, indicating that a three-band difference
was the maximal divergence (3 of 31 bands equals approxi-
mately 10%). All of the strains from the hospital in Bursa
cluster at the top of Fig. 2 (see boxed region). This indicates
that resident strains established in a given hospital evolve,
albeit slowly, and may in the end present as a separate, novel
genetic entity. All of the control strains included in the present
study were representatives of some of the major European
MRSA clones and were clearly more distant from the study
strains at the PFGE type level. Additional studies into the
precise nature of the mec region may shed light on the arche-
type from which the present Turkish MRSA isolates de-
scended (7).
Consequently, it can be concluded that 38 of 39 of the
MRSA isolates belong to a single, genetically homogeneous
cluster of strains. Only strain C5 had aberrant results; this
isolate was possibly imported and was not a local nosocomially
acquired resident strain. Strains from the single hospital that
was remote from the others tended to cluster separately, but
the genetic distance to the Ankara strains was still limited.
Spread of MRSA isolates. A primarily clonal spread of
MRSA has been suggested (8), whereas other reports suggest
that multiple episodes of horizontal gene transfer among
staphylococci have occurred and that multiple major MRSA
clones exist (9). Examples of the latter phenomenon in which
major MRSA clones successfully spread over large geographic
areas have recently been documented. Nationwide dispersal of
a given MRSA genotype has been demonstrated for several
West European countries such as Belgium (15), Poland (19),
and Germany (25). In Portugal and Spain a major MRSA type
crossed borders and became highly prevalent in both countries
(14). The United Kingdom also has a history of major episodes
of colonization and infection caused by epidemic MRSA
strains (4). Outside of Europe, other epidemic MRSA isolates
have also been described (16). On the contrary, several insti-
tutions have described an increase in the number of different
MRSA genotypes encountered among their patients (3). This
may be explained by an increase in the number of people in the
general population colonized with MRSA. This conclusion was
underscored by a recent pan-European surveillance of the
prevalence of MRSA in which it was emphasized that both
epidemic and nonepidemic MRSA isolates exist and that these
types may coexist in the same environment (24). The factors
that determine whether a strain becomes responsible for an
epidemic are largely unknown (22), but it is obvious that large
differences in the behaviors of MRSA isolates from different
clinical settings can be observed. For that reason it is worth-
while to continue the search for epidemic MRSA strains and,
after identification, study those particular strains in more detail
with respect to the determinants that cause the spread.
A single clone of MRSA in Turkey.We have shown here that
a major MRSA clone circulates in hospitals in the Ankara and
Bursa regions of Turkey. With the help of genetic typing pro-
cedures, the genetic homogeneity among Turkish MRSA iso-
lates is well established. Apparently, the MRSA strain involved
is very well adapted to the clinical setting and is capable of
dissemination and local maintenance. It remains to be seen
whether the Turkish clone is genetically similar to one of the
other major European MRSA types, although preliminary data
reveal that no obvious homologies with two Polish and the
Iberian clones of MRSA seem to exist at the DNA level.
Preliminary data on the genetic resemblance of strains from
Istanbul, Turkey, which is 440 km away from Ankara, already
indicate that in the Turkish capital strains belonging to the
same clonal lineage can also be identified (1). When analyzing
the strains from Bursa and comparing them to the ones from
Ankara, subtle genetic differences were observed: strains from
Bursa tend to cluster separately, but are not distant. Appar-
ently, local adaptation or small-scale evolution occurs once the
strains become geographically isolated.
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